Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Shanghai Junshi Biopharmaceuticals Co., Ltd. Announcement on Returning Idle Raised Funds Temporarily Used to Supplement Working Capital
Securities Code: 688180
Securities Name: Junshi Biosciences
Announcement No.: 临2026-008
Shanghai Junshi Biosciences Biotechnology Co., Ltd.
Announcement on Repayment of Idle Raised Funds Temporarily Used to Supplement Working Capital
The company’s board of directors and all directors guarantee that this announcement contains no false records, misleading statements, or major omissions, and bear legal responsibility for the truthfulness, accuracy, and completeness of its content.
Shanghai Junshi Biosciences Biotechnology Co., Ltd. (hereinafter referred to as “the Company”) held the seventh meeting of the fourth board of directors on March 27, 2025, which approved the proposal on using part of the idle raised funds to temporarily supplement working capital. The Company agreed to use no more than RMB 2 billion (including this amount) of idle raised funds for this purpose, solely for business expansion, daily operations, and other production and management activities related to its main business. The usage period shall not exceed 12 months from the date of approval by the board of directors. The Company will repay the funds to the dedicated account for raised funds in a timely manner based on the progress and needs of the investment projects funded by the raised capital. For details, please refer to the company’s announcement titled “Announcement on Using Part of Idle Raised Funds to Temporarily Supplement Working Capital” published on the Shanghai Stock Exchange website (www.sse.com.cn) on March 28, 2025 (Announcement No.: 临2025-015).
According to the above resolution, the company actually used RMB 1,106,341,600 of idle raised funds to temporarily supplement working capital within the specified period, and has arranged and used the funds reasonably without affecting the normal progress of the investment projects funded by the raised capital.
As of the date of this announcement, the company has fully repaid the RMB 1,106,341,600 of idle raised funds to the dedicated account for raised funds, and has notified the sponsor institution and sponsor representatives of the repayment status.
This announcement is hereby made.
Shanghai Junshi Biosciences Biotechnology Co., Ltd.
Board of Directors
March 13, 2026